GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AusCann Group Holdings Ltd (ASX:AC8) » Definitions » Total Payout Ratio

AusCann Group Holdings (ASX:AC8) Total Payout Ratio : 0.00 (As of Apr. 27, 2024)


View and export this data going back to 1986. Start your Free Trial

What is AusCann Group Holdings Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

AusCann Group Holdings's current Total Payout Ratio is 0.00.


AusCann Group Holdings Total Payout Ratio Historical Data

The historical data trend for AusCann Group Holdings's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AusCann Group Holdings Total Payout Ratio Chart

AusCann Group Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.60 - - - -

AusCann Group Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AusCann Group Holdings's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, AusCann Group Holdings's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AusCann Group Holdings's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AusCann Group Holdings's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where AusCann Group Holdings's Total Payout Ratio falls into.



AusCann Group Holdings Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

AusCann Group Holdings's Total Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -1.045
=0.00

AusCann Group Holdings's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -0.052
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AusCann Group Holdings Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of AusCann Group Holdings's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AusCann Group Holdings (ASX:AC8) Business Description

Traded in Other Exchanges
Address
35 Havelock Street, Level 5, West Perth, Perth, WA, AUS, 6005
AusCann Group Holdings Ltd produces medicinal cannabis. It delivers high-quality, economical, and clinically validated cannabinoid medicinal products.

AusCann Group Holdings (ASX:AC8) Headlines

No Headlines